Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
Clinical trial NCT02583516 · COMPLETED
Trial details
- NCT number
- NCT02583516
- Sponsor
- Grupo Español Multidisciplinar de Melanoma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-30
- Primary completion
- 2019-09-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.